Market Closed -
Nyse
04:00:01 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
70.36
USD
|
+1.03%
|
|
+1.76%
|
+6.61%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,797
|
3,125
|
4,205
|
3,065
|
2,788
|
2,979
|
-
|
-
|
Enterprise Value (EV)
1 |
3,395
|
3,627
|
4,691
|
3,695
|
3,418
|
3,574
|
3,481
|
3,413
|
P/E ratio
|
34.1
x
|
28.5
x
|
35.6
x
|
21.8
x
|
29.9
x
|
24.3
x
|
21.3
x
|
17.5
x
|
Yield
|
2.22%
|
2.11%
|
1.58%
|
2.25%
|
2.48%
|
2.39%
|
2.44%
|
2.63%
|
Capitalization / Revenue
|
2.11
x
|
2.35
x
|
3.05
x
|
2.13
x
|
1.91
x
|
1.98
x
|
1.91
x
|
1.77
x
|
EV / Revenue
|
2.57
x
|
2.72
x
|
3.4
x
|
2.57
x
|
2.35
x
|
2.37
x
|
2.23
x
|
2.02
x
|
EV / EBITDA
|
15.3
x
|
16.6
x
|
19.4
x
|
14.1
x
|
13.7
x
|
14.1
x
|
12.8
x
|
10.9
x
|
EV / FCF
|
24.6
x
|
21.8
x
|
55.6
x
|
-54.9
x
|
41.8
x
|
33.8
x
|
30.8
x
|
24.5
x
|
FCF Yield
|
4.07%
|
4.59%
|
1.8%
|
-1.82%
|
2.39%
|
2.95%
|
3.24%
|
4.08%
|
Price to Book
|
3.17
x
|
3.35
x
|
4.48
x
|
3.08
x
|
2.65
x
|
2.69
x
|
2.51
x
|
2.32
x
|
Nbr of stocks (in thousands)
|
42,319
|
42,357
|
42,026
|
42,038
|
42,250
|
42,344
|
-
|
-
|
Reference price
2 |
66.09
|
73.77
|
100.1
|
72.92
|
66.00
|
70.36
|
70.36
|
70.36
|
Announcement Date
|
2/14/20
|
2/12/21
|
2/11/22
|
2/10/23
|
2/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,323
|
1,332
|
1,380
|
1,437
|
1,456
|
1,506
|
1,562
|
1,686
|
EBITDA
1 |
221.3
|
218.6
|
241.9
|
262.8
|
249.6
|
253.8
|
272.6
|
313.3
|
EBIT
1 |
167
|
163.6
|
180.4
|
194.2
|
182.9
|
194.6
|
210.9
|
246.4
|
Operating Margin
|
12.62%
|
12.28%
|
13.07%
|
13.52%
|
12.56%
|
12.92%
|
13.5%
|
14.62%
|
Earnings before Tax (EBT)
1 |
101
|
137.8
|
157.5
|
182.2
|
-
|
158
|
193
|
224
|
Net income
1 |
82.05
|
109.5
|
118.7
|
140.9
|
93.39
|
119.3
|
146.1
|
169.2
|
Net margin
|
6.2%
|
8.22%
|
8.6%
|
9.8%
|
6.41%
|
7.92%
|
9.35%
|
10.04%
|
EPS
2 |
1.940
|
2.590
|
2.810
|
3.340
|
2.210
|
2.890
|
3.305
|
4.010
|
Free Cash Flow
1 |
138.1
|
166.6
|
84.43
|
-67.25
|
81.83
|
105.6
|
112.9
|
139.3
|
FCF margin
|
10.44%
|
12.51%
|
6.12%
|
-4.68%
|
5.62%
|
7.01%
|
7.23%
|
8.26%
|
FCF Conversion (EBITDA)
|
62.41%
|
76.2%
|
34.91%
|
-
|
32.78%
|
41.61%
|
41.41%
|
44.46%
|
FCF Conversion (Net income)
|
168.3%
|
152.2%
|
71.1%
|
-
|
87.62%
|
88.52%
|
77.28%
|
82.33%
|
Dividend per Share
2 |
1.470
|
1.560
|
1.580
|
1.640
|
1.640
|
1.680
|
1.720
|
1.850
|
Announcement Date
|
2/14/20
|
2/12/21
|
2/11/22
|
2/10/23
|
2/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
342.7
|
340.4
|
355.5
|
371.7
|
361.1
|
348.7
|
369
|
374.3
|
363.8
|
349.3
|
384.7
|
383.4
|
379.1
|
362.1
|
EBITDA
1 |
62.96
|
58.06
|
70.01
|
68.37
|
60.58
|
55.56
|
67.26
|
66.03
|
61.82
|
52.01
|
68.92
|
67
|
66
|
57.8
|
EBIT
1 |
47.75
|
41.69
|
52.79
|
55.24
|
47.49
|
38.69
|
50.84
|
51.59
|
44.53
|
35.9
|
52.22
|
52.5
|
51.5
|
43.3
|
Operating Margin
|
13.94%
|
12.25%
|
14.85%
|
14.86%
|
13.15%
|
11.1%
|
13.78%
|
13.78%
|
12.24%
|
10.28%
|
13.57%
|
13.69%
|
13.58%
|
11.96%
|
Earnings before Tax (EBT)
|
43.92
|
37.67
|
49.8
|
52.16
|
43.82
|
36.43
|
44.84
|
45.24
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
33.91
|
27.23
|
37.07
|
38.65
|
36.05
|
29.12
|
33.65
|
34.03
|
-
|
-5.833
|
-
|
-
|
-
|
-
|
Net margin
|
9.9%
|
8%
|
10.43%
|
10.4%
|
9.98%
|
8.35%
|
9.12%
|
9.09%
|
-
|
-1.67%
|
-
|
-
|
-
|
-
|
EPS
2 |
0.8000
|
0.6500
|
0.8800
|
0.9200
|
0.8500
|
0.6900
|
0.8000
|
0.8100
|
0.7500
|
-0.1400
|
0.7300
|
0.8100
|
0.7900
|
0.6500
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/15/21
|
2/11/22
|
4/29/22
|
7/22/22
|
10/21/22
|
2/10/23
|
4/28/23
|
7/21/23
|
10/20/23
|
2/8/24
|
4/26/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
598
|
502
|
486
|
630
|
630
|
595
|
502
|
434
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.702
x
|
2.298
x
|
2.009
x
|
2.396
x
|
2.522
x
|
2.344
x
|
1.841
x
|
1.385
x
|
Free Cash Flow
1 |
138
|
167
|
84.4
|
-67.3
|
81.8
|
106
|
113
|
139
|
ROE (net income / shareholders' equity)
|
14.4%
|
13%
|
14.1%
|
14.3%
|
11.8%
|
11.5%
|
12.4%
|
13.3%
|
ROA (Net income/ Total Assets)
|
7.03%
|
6.79%
|
-
|
7.46%
|
-
|
-
|
-
|
-
|
Assets
1 |
1,168
|
1,611
|
-
|
1,889
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
20.90
|
22.00
|
22.40
|
23.70
|
24.90
|
26.20
|
28.00
|
30.30
|
Cash Flow per Share
|
4.190
|
5.170
|
3.440
|
0.2900
|
4.020
|
-
|
-
|
-
|
Capex
1 |
39.1
|
52.2
|
60.8
|
79.3
|
87.9
|
76.1
|
72
|
75.9
|
Capex / Sales
|
2.96%
|
3.92%
|
4.4%
|
5.52%
|
6.03%
|
5.05%
|
4.61%
|
4.5%
|
Announcement Date
|
2/14/20
|
2/12/21
|
2/11/22
|
2/10/23
|
2/8/24
|
-
|
-
|
-
|
Last Close Price
70.36
USD Average target price
74
USD Spread / Average Target +5.17% Consensus |
1st Jan change
|
Capi.
|
---|
| +6.61% | 2.98B | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|